Apnimed,
APMDOther · NASDAQ · IPO July 10, 2026
01
Company Overview
Apnimed, is filing to list on an exchange. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Apnimed, is going public on an exchange on 2026-07-10.
Recent headlines
- Apnimed files for IPO as FDA reviews its sleep apnea drugendpoints.news
Apnimed files for Nasdaq IPO under the ticker $APMD, three months after submitting its sleep apnea drug AD109 for FDA approval.
- Sleep apnea pill maker Apnimed files for US IPO as biotech market revivesreuters.com
July 10 (Reuters) - Apnimed, a late-stage clinical pharmaceutical company, filed for an initial public offering in the U.S. on Friday.
- Apnimed IPO Filing: De-Risked Biotech With PDUFA...allsci.com
Apnimed files for Nasdaq IPO with completed Phase III trials and NDA submission. PDUFA decision expected Q1 2027.
- Apnimed Files IPO as Its Once-Nightly OSA Pill Nears an FDA Decisionsleepworldmagazine.com
Apnimed Files IPO as Its Once-Nightly OSA Pill Nears an FDA Decision July 13, 2026. The company is expected to list on Nasdaq under the ticker ...
- Pharmaceutical Company Apnimed Files for IPOmorningstar.com
Apnimed, a pharmaceutical company developing a treatment for sleep apnea, filed for an initial public offering. stock on the Nasdaq Global ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- July 10, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Other
- Valuation
- $100.0M raise
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- APMD